Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · CIK 1294133 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $6.43Day +0.16%Mkt cap $174M1Y −2.6%Off 52W high −29.6%Vol (1Y) 45.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 3,128 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.9% of sh out |
| Days to cover5.2d |
| 13F net flow (QoQ)+2.03% |
| Top-10 13F concentration47.9% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$351.5M |
| Earnings (TTM)-$24.9M |
| ROE−12.4% |
| Net margin−6.5% |
| ROIC−32.1% |
| Sales growth 3Y−2.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−4.3% |
| 1Y−2.6% |
| 3Y−21.3% |
| 5Y−91.9% |
| 10Y−88.0% |
| Since incept. (ann.)−6.7% |
Total return through 2026-07-29 · series begins 2014-02-14. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)45.4% |
| Ann. volatility (3Y)64.8% |
| Sharpe (1Y)0.10 |
| Sharpe (3Y)0.20 |
| Max drawdown (1Y)−37.5% |
| Max drawdown (3Y)−56.9% |
| Beta (3Y vs SPY)2.06 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 1.6M | $10M | 6.08% | −4.1% |
| ARMISTICE CAPITAL, LLC | 1.2M | $7M | 4.43% | −5.1% |
| ACADIAN ASSET MANAGEMENT LLC | 1.1M | $7M | 4.00% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $6M | 3.83% | new |
| AMERIPRISE FINANCIAL INC | 859,543 | $5M | 3.17% | −0.1% |
| DAFNA Capital Management LLC | 845,179 | $5M | 3.12% | +2.2% |
| Point72 Asset Management, L.P. | 642,366 | $4M | 2.37% | +218.1% |
| GEODE CAPITAL MANAGEMENT, LLC | 613,529 | $4M | 2.27% | +2.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.30 | — | $85.1M | +3.4% |
| 2025-12-31 | 2026-02-24 | — | — | $81.7M | +2.0% |
| 2025-09-30 | 2025-11-05 | −$0.20 | — | $92.4M | +4.0% |
| 2025-06-30 | 2025-08-07 | −$0.15 | — | $92.3M | +4.0% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
US 60% · Non Us 40%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
